Long-term Survival in Glioblastoma with Cytomegalovirus pp65-targeted Vaccination

PURPOSE: Patients with glioblastoma (GBM) have a <15 month median survival despite surgical resection, high-dose radiation and chemotherapy with temozolomide (TMZ). We previously demonstrated that targeting Cytomegalovirus (CMV) pp65 using dendritic cells (DCs) can extend survival and, in a separ...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Clin Cancer Res
Main Authors: Batich, Kristen A., Reap, Elizabeth A., Archer, Gary E., Sanchez-Perez, Luis, Nair, Smita K., Schmittling, Robert J., Norberg, Pam, Xie, Weihua, Herndon, James E., Healy, Patrick, McLendon, Roger E., Friedman, Allan H., Friedman, Henry S., Bigner, Darell, Vlahovic, Gordana, Mitchell, Duane A., Sampson, John H.
Formato: Artigo
Idioma:Inglês
Publicado em: 2017
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5559300/
https://ncbi.nlm.nih.gov/pubmed/28411277
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/1078-0432.CCR-16-2057
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados